Viewing Study NCT00836667


Ignite Creation Date: 2025-12-25 @ 12:44 AM
Ignite Modification Date: 2026-03-01 @ 9:54 PM
Study NCT ID: NCT00836667
Status: COMPLETED
Last Update Posted: 2024-08-19
First Post: 2009-02-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sertraline Hydrochloride 100 mg Tablets, Fed
Sponsor: Teva Pharmaceuticals USA
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module